Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totalling 25,000 shares, a drop of 11.0% from the November 30th total of 28,100 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright raised Basilea Pharmaceutica to a "strong-buy" rating in a research report on Monday, September 23rd.
Read Our Latest Report on BPMUF
Basilea Pharmaceutica Price Performance
Shares of Basilea Pharmaceutica stock remained flat at $52.83 during trading hours on Monday. Basilea Pharmaceutica has a 1 year low of $38.60 and a 1 year high of $52.83. The business's 50-day moving average is $52.83 and its two-hundred day moving average is $50.70.
About Basilea Pharmaceutica
(
Get Free Report)
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Read More
Before you consider Basilea Pharmaceutica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Basilea Pharmaceutica wasn't on the list.
While Basilea Pharmaceutica currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
